Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Jafron Biomedical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Stock Price

¥32

2024-10-29

Market Capitalization

¥25.1 B

2024-10-29

Revenue

¥1.9 B

FY, 2023

CreditSafe Score

?
Score changed on Feb 12, 2025
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

CNYFY, 2018FY, 2019FY, 2020FY, 2021FY, 2022FY, 2023
Revenue994.8M1.4B1.9B2.6B2.5B1.9B
Cost of goods sold154.4M197.4M288.0M402.1M440.1M384.0M
Gross profit843.2M1.2B1.6B2.2B2.0B1.5B
Gross profit margin, %84.8%86.2%85.2%84.9%82.2%79.8%
Operating expense total410.7M575.8M631.5M854.0M1.0B948.3M
Depreciation and amortization21.8M29.8M36.7M49.2M75.3M117.2M
EBITDA432.5M636.0M1.0B1.4B992.6M558.2M
EBITDA margin, %43.5%45.2%52.3%52.4%40.5%29.6%
EBIT429.2M627.2M989.6M1.4B988.5M487.1M
EBIT margin, %43.1%44.6%51.6%51.9%40.3%25.8%
Interest income5.4M9.6M28.8M27.8M53.3M88.0M
Interest expense8.9M36.0M54.3M
Pre tax profit473.1M671.3M1.0B1.4B1.0B521.0M
Income tax expense72.2M102.6M159.0M211.4M135.9M95.3M
Net Income400.9M568.7M873.0M1.2B880.9M425.7M

Footer menu